AbbVie (ABBV) reported its Q2 2026 financial results on July 31, 2026, before market open. The company reported quarterly earnings per share (EPS) of 3.65 USD, beating the analyst estimate of 3.61 USD by 1.2%. Quarterly revenue reached 16990 million USD. Following the publication, the stock price fell by 2.51%.
Generated automatically from our data — as of August 6, 2026
Key figures at a glance
Estimate (EPS): 3.61 USD
Reported (EPS): 3.65 USD
Price reaction: -2.5%
Frequently asked questions
Did AbbVie beat or miss earnings-per-share expectations?
AbbVie beat the analyst estimate of 3.61 USD earnings per share (Q2 2026) by 1.2%, reporting 3.65 USD.
How did AbbVie stock react to the earnings report?
AbbVie stock fell 2.5% on the trading day following the release.
What was AbbVie's revenue in Q2 2026?
AbbVie reported revenue of 16,990M USD in Q2 2026.